C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
11/2006
11/15/2006	CN1864443A Use of a layer consisting of hydrophobic, linear or two-dimensional polycyclic aromatics as a barrier layer or an encapsulation and electric components constructed with a layer of this type and compri
11/15/2006	CN1863891A Organic compound and organic light emitting device using the same
11/15/2006	CN1863806A 4-biphenylsubstituted pyrazolidin-3,5-dione derivatives
11/15/2006	CN1863804A Certain substituted spirocyclic lactams and use thereof as pharmaceuticals
11/15/2006	CN1863803A 嘧啶衍生物 Pyrimidine derivatives
11/15/2006	CN1861603A Silicon phthalocyanine compound and composite, their preparation and application thereof
11/15/2006	CN1861077A Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
11/15/2006	CN1284784C Blue modifier and its preparation process and application
11/15/2006	CN1284783C Substituted nitrogen contg. heterocycles as inhibitors of P38 progein kinase
11/15/2006	CN1284782C Fungicidal triazolopyrimidines, method for production thereof and use thereof in controlling noxious fungi and agents containing said compounds
11/15/2006	CN1284771C TNF－α生成抑制剂 TNF-α production inhibitor
11/14/2006	US7136275 Polymeric dielectric material for high-energy density capacitors
11/14/2006	US7135575 P38 inhibitors and methods of use thereof
11/14/2006	US7135568 Substituted pyrazolopyrimidines and thiazolopyrimidines
11/14/2006	US7135550 Three hybrid assay system
11/14/2006	US7135494 Antitumoral carbazoles
11/14/2006	US7135493 HDAC inhibitor
11/14/2006	US7135480 Substituted 1-benzoyl-3-cyano-pyrrolo [1,2-a] quinolines and analogs as activators of caspases and inducers of apoptosis
11/14/2006	US7135476 Corticotropin releasing factor antagonists; anxiolytic agents; (2,3,5',6',-Tetrahydro)-2'-methyl-4'-(N-propyl-N-cylopropylmethyl-amino) spiro[(1H)indene-1,8'-(7H)quinazoline]; (2,3,5',6',-Tetrahydro)-2'-methyl-4'-(N-propyl-N-cylopropylmethyl-amino) spiro[(1H)indene-1,7'-(5H)cyclopentapyrimidine]
11/14/2006	CA2128955C Tricyclic benzazepine vasopressin antagonists
11/14/2006	CA2128493C Aminobenzoic acid derivatives
11/09/2006	WO2006119504A2 Fused heterocyclic compounds, and compositions and uses thereof
11/09/2006	WO2006118598A1 Bicycloheteroarylamine compounds as ion channel ligands and uses thereof
11/09/2006	WO2006118341A1 Novel lactam compound
11/09/2006	WO2006117672A2 Detection of ortho-diamine residues in analytes containing residual cyclizing agents
11/09/2006	WO2006117549A1 Enzyme inhibitors
11/09/2006	WO2006117399A1 Phthalocyanine derivatives, process for their preparation, pharmaceutical compositions containing them, and their use
11/09/2006	WO2006117396A2 Process for preparing chlorides of phthalocyanine derivatives comprising at least a quaternary ammonium group
11/09/2006	WO2006099940A8 Substituted, bicyclic 8-pyrrolidino-benzimidazoles, method for their production and their use as medicaments
11/09/2006	WO2006074293A3 Bicyclic dihydropyrimidines as eg5 inhibitors
11/09/2006	WO2006019673A3 Jiadifenin analogs and uses thereof
11/09/2006	WO2005074603A3 Aminobenzoxazoles as therapeutic agents
11/09/2006	US20060252931 New CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions
11/09/2006	US20060252784 Imidazo-substituted 1,8-naphthyridinylamines; treating arthritis, Crohn's disease, Alzheimer's disease, irritable bowel syndrome, adult respiratory distress syndrome, and chronic obstructive pulmonary disease.
11/09/2006	US20060252783 Imidazo-substituted pyrido[2,3-d]pyrimidinylamines; treating arthritis, Crohn's disease, Alzheimer's disease, irritable bowel syndrome, adult respiratory distress syndrome, and chronic obstructive pulmonary disease.
11/09/2006	US20060252782 Sulfoximine-macrocycle compounds and salts thereof, pharmaceutical compositions comprising said compounds, methods of preparing same and uses of same
11/09/2006	US20060252781 Fused heterocycles as inhibitors of glutamate racemase(muri)
11/09/2006	US20060252780 Fused pyrimidine derivatives
11/09/2006	US20060252778 Compounds for the treatment of inflammatory disorders
11/09/2006	US20060252777 5-[4-(6,7-Dimethoxy-quinolin-4-yloxy)-3-fluoro-phenyl]-2-(4-fluoro-phenylamino)-3-methyl-3H-pyrimidin-4-one; anticarcinogenics, antimetastasis agents, antiproliferatives, angiogenesis inhibitors; hepatocyte growth factor mediated diseases
11/09/2006	US20060252760 Farnesyl transferase inhibitors
11/09/2006	US20060252758 sodium channel modulators such as 1'-pentylspiro[furo[2,3-f][1,3]benzodioxole-7,3'-pyrrolo[2,3-b]pyridin]-2'(1'H)-one, useful as for the treatment of nervous system disorders, cardiovascular disorders, muscular disorders and as neuroprotectants or as analgesics
11/09/2006	US20060251725 Aggregation of particle sizes
11/09/2006	US20060251588 Delivery of erectile dysfunction drugs through an inhalation route
11/09/2006	US20060251587 Delivery of analgesics through an inhalation route
11/09/2006	CA2607572A1 Phthalocyanine derivatives, process for their preparation, pharmaceutical compositions containing them, and their use
11/09/2006	CA2607571A1 Process for preparing chlorides of phthalocyanine derivatives comprising at least a quaternary ammonium group
11/09/2006	CA2607506A1 Novel lactam compound
11/09/2006	CA2606760A1 Tetrahydronaphthyridine and tetrahydropyrido[4,3-d]pyrimidine compounds and compositions thereof useful in the treatment of conditions associated with neurological and inflammatory disorders and disfunctions
11/09/2006	CA2606664A1 Detection of ortho-diamine residues in analytes containing residual cyclizing agents
11/09/2006	CA2599411A1 Enzyme inhibitors
11/08/2006	EP1719773A1 Fused heterotetracyclic compounds and use tehreof as hcv polymerase inhibitor
11/08/2006	EP1719768A1 Novel benzothiazepine and benzothiepine compounds
11/08/2006	EP1719765A1 Novel sulfone amide derivative
11/08/2006	EP1719763A1 Novel pyridine derivative and pyrimidine derivative (2)
11/08/2006	EP1719762A1 Novel pyridine derivative and pyrimidine derivative (1)
11/08/2006	EP1719761A1 Novel heterocyclic compound
11/08/2006	EP1719756A1 Nitrogenous fused heteroaromatic ring derivative
11/08/2006	EP1718652A2 Pyrazolopyrimidines for combatting unwanted microorganisms
11/08/2006	EP1718651A2 7h-pyrrolopyrimidine derivatives
11/08/2006	EP1718650A1 Imidazolopyrimidines used as fungicidal active ingredients
11/08/2006	EP1718649A2 Imidazo 1,2-c pyrimidinylacetic acid derivatives
11/08/2006	EP1718647A1 Prodrugs of substituted amino heterobicycles which modulate the function of the vanilloid-1 receptor (vr1)
11/08/2006	EP1718645A1 2-(pyridin-3-ylamino)-pyrido 2,3-d pyrimidin-7-ones
11/08/2006	EP1718624A1 Benzamide derivatives and their use as glucokinase activating agents
11/08/2006	EP1718608A1 Viral polymerase inhibitors
11/08/2006	EP1718300A2 Conformationally constrained smac mimetics and the uses thereof
11/08/2006	EP1718299A1 Heterocyclic gaba-a subtype selective receptor modulators
11/08/2006	EP1718201A1 Substituted porphyrins
11/08/2006	EP1718152A2 Aminocyclopentyl pyridopyrazinone modulators of chemokine receptor activity
11/08/2006	EP1587810B1 Novel substituted 1,4\|benzodioxino 2,3-e\|isoindole derivatives, method for preparing same and pharmaceutical compositions containing same
11/08/2006	EP1303514B9 Process for preparing azacycloalkanoylaminothiazoles
11/08/2006	EP1021190B1 Amid derivatives as growth hormone release promotors
11/08/2006	CN1860121A Substituted imidazopyrimidines for the prevention and treatment of cancer
11/08/2006	CN1860118A Compounds and compositions as protein kinase inhibitors
11/08/2006	CN1859847A 杀真菌混合物 Fungicide mixture
11/08/2006	CN1283642C Process for the preparation of highly pure triethylene diamine
11/08/2006	CN1283253C Use of desoxypeganine in preparing drugs for treating clinical depression
11/07/2006	US7132553 Inhibitor is a (2-amino-(optionally -1-oxo)-3-thiopropyl)--5,6,7,8-tetrahydroimidazo[1,2a]pyrazine derivative or its disulfide dimer, e.g., (2-amino-1-oxo-3-thiopropyl)-8-(cyclohexylmethyl)-2-phenyl-5,6,7,8-tetrahydroimidazo[1,2a]pyrazine
11/07/2006	US7132538 Isolation of high-purity triethylenediamine (TEDA) by distillation
11/07/2006	US7132536 Endothelial nitric oxide synthase expression stimulants; cardiovascular disorders
11/07/2006	US7132533 Tricyclic compounds protein kinase inhibitors for enhancing the efficacy of anti-neoplastic agents and radiation therapy
11/07/2006	US7132426 Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
11/07/2006	US7132423 e.g., N-Cycloheptyl-N'(1-ethyl-pyrrolidin-2-ylmethyl)-6-(3-fluoro-4-methoxy-phenoxy)-[1,3,5]triazine-2,4-diamine; treating unwanted cellular proliferation, an inflammation mediated disease, or a hyperproliferative disease, or modulating a glycosidase enzyme
11/07/2006	CA2274093C Substituted pyrimidinone and pyridinone compounds and their use
11/07/2006	CA2192824C Pyridone-carboxylic acid derivatives, processes for the preparation thereof and anti-tumor agents containing the pyridone-carboxylic acid derivatives
11/07/2006	CA2146961C Heterobicyclic sulfonamide and sulfonic ester derivatives
11/02/2006	WO2006116764A1 Polycyclic carbamoylpyridone derivative having hiv integrase inhibitory activity
11/02/2006	WO2006116733A2 Protein kinase inhibitors
11/02/2006	WO2006116713A1 Substituted amide derivatives as protein kinase inhibitors
11/02/2006	WO2006116412A2 Fused heterocyclic compounds
11/02/2006	WO2006116355A1 Ortho-terphenyl inhibitors of p38 kinase and methods of treating inflammatory disorders
11/02/2006	WO2006114706A1 Triazole derivatives as vasopressin antagonists
11/02/2006	WO2006114575A1 Novel development accelerator-releasing couplers
11/02/2006	WO2006114313A1 Pyrazole compounds as prostaglandin receptors ligands
11/02/2006	WO2006114274A1 Oxazole and thiazole compounds and their use in the treatment of pge2 mediated disorders
11/02/2006	WO2006114272A1 FURAN COMPOUNDS USEFUL AS EPl RECEPTOR ANTAGONISTS
11/02/2006	WO2006114260A1 Phenylacetylene derivatives having mglur5 receptor affinity
11/02/2006	WO2006091428A3 Heteroaryl substituted pyrazinyl-piperazine-piperidines with cxcr3 antagonist activity
11/02/2006	WO2006088836A3 Piperazine-piperidines with cxcr3 antagonist activity

1 ... 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 ... 573